Heublein B, Auricchio A, Wagenbreth I, Haverich A, Dieterich H A
Division of Cardiology, Hannover Medical School, Germany.
J Cardiovasc Surg (Torino). 1992 Jan-Feb;33(1):21-7.
Denervation of the heart involves an alteration (density, distribution of beta 1-beta 2-types) of beta-adrenoceptors in long-term follow-up. To elucidate the influence of these changes on left ventricular contractility and to provide an effective alternative treatment to re-transplantation in cases of chronic rejection (coronary vasculopathy-CVP, unspecific myocardial allograft failure-UMAF) a clinical study on 19 male transplant recipients after orthotopic heart transplantation without CVP and UMAF in the non-rejecting state was undertaken. Six male patients served as a control group to compare the systolic function at rest. Left ventricular end-systolic pressure-volume relationships (ESPVR) (k-slope) were registered and computer measured using a conductance catheter-technique under conditions of a transiently occluded vena cava and at a fixed heart rate (atrial pacing) in all patients (n = 25). In the transplanted patient group the acute response of enoximone (0.75 mg/kg) administered intravenously was recorded. The position of the ESPVR in the transplanted hearts were not different as compared to the data obtained from the non-transplanted hearts at rest. The k-slope increased from the baseline data after the acute infusion of enoximone in the transplanted hearts. The dosage of enoximone used produced a significant leftward shift in the ESPVR in most patients (89%). In addition, 42% of the patients showed an insignificant drop in left ventricular systolic pressure. Thus, the baseline contractile characteristics of the heart transplant recipients without chronic rejection and in the non-rejecting state is not obviously different from those in non-transplanted patients at rest independent of the time since operation.(ABSTRACT TRUNCATED AT 250 WORDS)
长期随访发现,心脏去神经支配会导致β肾上腺素能受体发生改变(β1 - β2型的密度、分布)。为了阐明这些变化对左心室收缩功能的影响,并为慢性排斥反应(冠状动脉血管病变 - CVP、非特异性心肌移植失败 - UMAF)情况下的再次移植提供一种有效的替代治疗方法,对19例接受原位心脏移植且处于非排斥状态、无CVP和UMAF的男性移植受者进行了一项临床研究。选取6例男性患者作为对照组,比较静息时的收缩功能。在所有患者(n = 25)中,在短暂阻断腔静脉并固定心率(心房起搏)的条件下,使用电导导管技术记录并计算机测量左心室收缩末期压力 - 容积关系(ESPVR)(k斜率)。在移植患者组中,记录静脉注射依诺昔酮(0.75 mg/kg)后的急性反应。与静息时从非移植心脏获得的数据相比,移植心脏中ESPVR的位置没有差异。在移植心脏中,急性输注依诺昔酮后,k斜率从基线数据开始增加。所用依诺昔酮剂量在大多数患者(89%)中使ESPVR显著向左移位。此外,42%的患者左心室收缩压有不显著下降。因此,无慢性排斥反应且处于非排斥状态的心脏移植受者的基线收缩特性与静息时的非移植患者相比,在术后时间不同的情况下并无明显差异。(摘要截取自250字)